Symptomatology of COVID-19 from the otorhinolaryngology perspective: a survey of 223 SARS-CoV-2 RNA-positive patients
| Autor: | Bilge Türk, Alperen Aybal, Merve Ekici Bektaş, Ilyas Dokmetas, Suat Turgut, Safiye Nur Ozcan, Egehan Salepci |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Disease ENT symptoms 03 medical and health sciences Olfaction Disorders Otolaryngology Young Adult 0302 clinical medicine Internal medicine medicine Sore throat Humans Respiratory symptoms 030223 otorhinolaryngology Aged Aged 80 and over business.industry SARS-CoV-2 Smell loss COVID-19 General Medicine Middle Aged Miscellaneous Otorhinolaryngology Cough 030220 oncology & carcinogenesis Population study RNA Viral Female Neurosurgery medicine.symptom business Taste loss |
| Zdroj: | European Archives of Oto-Rhino-Laryngology |
| ISSN: | 1434-4726 |
| Popis: | Purpose To determine prevalence, severity, duration, and time from onset to diagnosis of general and Otorhinolaryngologic symptoms related to COVID-19 in whole disease spectrum: from mild to critical patients. Methods All adult patients with positive SARS-CoV-2 RNA found in nasopharyngeal and oropharyngeal swabs between March 10 and April 21, 2020 were surveyed by the authors for new onset symptoms during disease course. Demographic features, general symptoms, and Otorhinolaryngological symptoms were evaluated and compared by disease severity. Results Of 223 included patients, 18.4% had mild, 61.4%; moderate, 14.3%; severe, and 5.8%; critical disease. Median age was 51 (range 20–93), 113 (50.7%) were male and 110 (49.3%) were female. The most common general symptoms were fatigue, cough, and fever with respective frequencies of 71.3%, 54.3%, and 50.7%. The most common Otorhinolaryngologic symptoms were taste loss, smell loss, and sore throat with respective frequencies of 34.5%, 31.8%, and 26%. Fatigue, fever, and dyspnea were more common in severe-critical patients compared to mild–moderate patients (p = 0.029, p = 0.016, and p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink